CELG Financial Facts
Royalty revenue: 28.2MInterest expense: -17.9M
See Full Income Statement
Total stockholders' equity: 5.55B
Long-term debt, net of discount: 2.76B
See Full Balance Sheet
Earnings History for Celgene Corporation (CELG)
|
Expand Research on CELG
| Next EPS Date | 7/25/13 *Est. | EPS Growth Rate | +26.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +1.8% | Revenue Growth Rate | +12.6% *Last Qtr. |
| Average % Move 1-Wk after EPS | +0.6% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/13  |
 |
Q113 | $1.37 | $1.35 | +$0.02 | $1.43B | $1.47B | N/A / N/A | N/A | -1.2% | Details |
| 1/24/13 |
Q412 | $1.32 | $1.31 | +$0.01 | $1.42B | $1.45B | N/A / N/A | N/A | +19% | Details | |
| 10/25/12 |
|
Q312 | $1.29 | $1.27 | +$0.02 | $1.42B | $1.41B | $1.29 / $1.42B | = | +57.8% | Details |
| 7/26/12 |
|
Q212 | $1.22 | $1.18 | +$0.04 | $1.37B | $1.35B | $1.19 / $1.35B | = | +79.1% | Details |
| 4/26/12 |
|
Q112 | $1.08 | $1.13 | -$0.05 | $1.27B | $1.32B | $1.15 / $1.33B | = | +50% | Details |
| 1/26/12 |
|
Q411 | $1.05 | $1.06 | -$0.01 | $1.24B | $1.29B | $1.04 / $1.33B | = | +58.4% | Details |
| 10/27/11 |
|
Q311 | $1.02 | $0.95 | +$0.07 | $1.25B | $1.2B | $0.99 / $1.26B |  |
+75.9% | Details |
| 7/28/11 | |
Q211 | $0.89 | $0.87 | +$0.02 | $1.18B | $1.12B | N/A / N/A | |
+96.5% | Details |
